Med Air Africa

medairafrica.com

Med Air Africa was founded with the vision to provide a higher level of medical care to clients in post-conflict and developing countries in Africa. Since our establishment in 2013, Med Air Africa has formed alliances with International Insurers and Assistance Companies by providing effective medical, aviation and logistic services to Government, NGOs and Mining Entities operating in Africa today. While our core focus is to provide effective health care solutions to the mining and exploration industry, our capacity to provide additional medical services grew during the Ebola outbreak in 2013.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Medical, Industry Outlook

INTRODUCING THE ANBIO ADL I1910: AN ELEGANT CLIA ANALYZER FOR COMPREHENSIVE CLINICAL TESTING

PRNewswire | July 12, 2023

news image

Anbio, a leading provider of innovative diagnostic solutions, proudly presents the Anbio ADL i1910, a fully automated, compact, and affordable CLIA analyzer designed to transform the landscape of clinical diagnostics. With its cutting-edge technology and versatile capabilities, the ADL i1910 offers a comprehensive range of qualitative and quantitative testing options for analytes in human serum, plasma, whole blood, and urine samples. The ADL i1910 utilizes a direct chemilumines...

Read More

MedTech, Medical

PATENT AWARDED FOR PRIMARY TEMPLATE-DIRECTED AMPLIFICATION, FURTHER STRENGTHENING BIOSKRYB GENOMICS’ CORE TECHNOLOGIES

Businesswire | August 21, 2023

news image

BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, today announced the issuance of a composition of matter patent, US Patent 11,643,682 by the U.S. Patent and Trademark Office related to its novel Primary Template-Directed Amplification (PTA) method and applications for research, diagnostics, and treatment. The patent is exclusively licensed to BioSkryb by St. Jude Children&rs...

Read More

MedTech

SPECTRUMX CONFIRMS NEXT STEP IN CLINICAL DEVELOPMENT OF RESPIRATORY DRUG CANDIDATE SPX-001 AFTER MHRA MEETING

SpectrumX | November 25, 2022

news image

SpectrumX, a UK-based healthcare and pharmaceutical company announces that following a constructive scientific advice meeting with the Medicines and Healthcare products Regulatory Agency on Monday, 14th November, the Company is prepared to move forward with the next stage in clinical development of its respiratory drug candidate SPX-001. Per regulatory guidelines, SpectrumX will submit a combined Clinical Trial and Ethics Committee application for a placebo-controlled phase Ib inf...

Read More

Cell and Gene Therapy, Industrial Impact

EXELIXIS AND SAIROPA ANNOUNCE FDA CLEARANCE OF IND APPLICATION

Exelixis | February 14, 2023

news image

On February 13, 2023, Exelixis, Inc., a leading global oncology firm innovating next-generation medicines and regimens at the forefront of cancer care and Sairopa B.V. (Sairopa), a renowned firm developing novel therapeutics for cancer by modulating the patient's immune system, announced that FDA has approved Sairopa's Investigational New Drug (IND) Application to assess the pharmacokinetics and safety of ADU-1805 in adults with advanced solid tumors. ADU-1805, being a m...

Read More
news image

Medical, Industry Outlook

INTRODUCING THE ANBIO ADL I1910: AN ELEGANT CLIA ANALYZER FOR COMPREHENSIVE CLINICAL TESTING

PRNewswire | July 12, 2023

Anbio, a leading provider of innovative diagnostic solutions, proudly presents the Anbio ADL i1910, a fully automated, compact, and affordable CLIA analyzer designed to transform the landscape of clinical diagnostics. With its cutting-edge technology and versatile capabilities, the ADL i1910 offers a comprehensive range of qualitative and quantitative testing options for analytes in human serum, plasma, whole blood, and urine samples. The ADL i1910 utilizes a direct chemilumines...

Read More
news image

MedTech, Medical

PATENT AWARDED FOR PRIMARY TEMPLATE-DIRECTED AMPLIFICATION, FURTHER STRENGTHENING BIOSKRYB GENOMICS’ CORE TECHNOLOGIES

Businesswire | August 21, 2023

BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, today announced the issuance of a composition of matter patent, US Patent 11,643,682 by the U.S. Patent and Trademark Office related to its novel Primary Template-Directed Amplification (PTA) method and applications for research, diagnostics, and treatment. The patent is exclusively licensed to BioSkryb by St. Jude Children&rs...

Read More
news image

MedTech

SPECTRUMX CONFIRMS NEXT STEP IN CLINICAL DEVELOPMENT OF RESPIRATORY DRUG CANDIDATE SPX-001 AFTER MHRA MEETING

SpectrumX | November 25, 2022

SpectrumX, a UK-based healthcare and pharmaceutical company announces that following a constructive scientific advice meeting with the Medicines and Healthcare products Regulatory Agency on Monday, 14th November, the Company is prepared to move forward with the next stage in clinical development of its respiratory drug candidate SPX-001. Per regulatory guidelines, SpectrumX will submit a combined Clinical Trial and Ethics Committee application for a placebo-controlled phase Ib inf...

Read More
news image

Cell and Gene Therapy, Industrial Impact

EXELIXIS AND SAIROPA ANNOUNCE FDA CLEARANCE OF IND APPLICATION

Exelixis | February 14, 2023

On February 13, 2023, Exelixis, Inc., a leading global oncology firm innovating next-generation medicines and regimens at the forefront of cancer care and Sairopa B.V. (Sairopa), a renowned firm developing novel therapeutics for cancer by modulating the patient's immune system, announced that FDA has approved Sairopa's Investigational New Drug (IND) Application to assess the pharmacokinetics and safety of ADU-1805 in adults with advanced solid tumors. ADU-1805, being a m...

Read More